Corcept Therapeutics Inc (NASDAQ: CORT) is 28.20% higher on its value in year-to-date trading and has touched a low of $20.84 and a high of $117.33 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CORT stock was last observed hovering at around $69.59 in the last trading session, with the day’s loss setting it -4.99%.
Currently trading at $64.60, the stock is -7.87% and -1.25% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.51 million and changing -7.17% at the moment leaves the stock 27.10% off its SMA200. CORT registered 179.05% gain for a year compared to 6-month gain of 42.60%. The firm has a 50-day simple moving average (SMA 50) of $65.4172 and a 200-day simple moving average (SMA200) of $50.82605.
The stock witnessed a 14.34% loss in the last 1 month and extending the period to 3 months gives it a 20.12%, and is -11.47% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.78% over the week and 9.16% over the month.
Corcept Therapeutics Inc (CORT) has around 500 employees, a market worth around $6.82B and $675.04M in sales. Current P/E ratio is 52.39 and Fwd P/E is 19.36. Profit margin for the company is 20.70%. Distance from 52-week low is 209.98% and -44.94% from its 52-week high. The company has generated returns on investments over the last 12 months (20.38%).
The EPS is expected to grow by 37.80% this year
498.0 institutions hold shares in Corcept Therapeutics Inc (CORT), with institutional investors hold 91.88% of the company’s shares. The shares outstanding are 105.11M, and float is at 93.22M with Short Float at 17.73%. Institutions hold 81.37% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 16.54 million shares valued at $537.36 million. The investor’s holdings represent 16.0391 of the CORT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 9.55 million shares valued at $310.4 million to account for 9.2943 of the shares outstanding. The other top investors are INGALLS & SNYDER LLC which holds 8.24 million shares representing 7.989 and valued at over $267.66 million, while RENAISSANCE TECHNOLOGIES LLC holds 6.7036 of the shares totaling 6.91 million with a market value of $224.59 million.
Corcept Therapeutics Inc (CORT) Insider Activity
The most recent transaction is an insider sale by Swisher Daniel N JR, the company’s Director. SEC filings show that Swisher Daniel N JR sold 2,200 shares of the company’s common stock on Apr 10 ’25 at a price of $70.22 per share for a total of $0.15 million. Following the sale, the insider now owns 0.0 shares.
Still, SEC filings show that on Mar 31 ’25, Maduck Sean disposed off 100,000 shares at an average price of $100.54 for $10.05 million. The insider now directly holds 85,622 shares of Corcept Therapeutics Inc (CORT).
